INDOCO REMEDIES
|
The Current P/E Ratio of INDOCO REMEDIES is 105.97.
Share Price | ₹337.9 | Jan 02,2025 |
Market Cap | ₹3,115.4 Cr | |
Earnings-TTM | ₹29.4 Cr | TTM-Consolidated Results |
Price/Earnings | 105.97x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INDOCO REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,115.4 Cr] as on Jan 02,2025
(/) Earnings [ ₹29.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 105.97x ]
Thus, for INDOCO REMEDIES , the investors are currently willing to pay 105.97 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDOCO REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDOCO REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of INDOCO REMEDIES
PE Ratio Performance Analysis for INDOCO REMEDIES
- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 36.57x.
- INDOCO REMEDIES 's operated at median p/e ratio of 28.57x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2020 at 79.99x.
- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 21.09x.
How does INDOCO REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INDOCO REMEDIES | 29.40 | 105.97 | 3,115.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 40.46 | 450,595.0 |
CIPLA LTD | 4,485.22 | 27.69 | 124,175.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 21.20 | 114,625.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.19 | 99,672.5 |
DIVIS LABORATORIES LTD | 1,836.00 | 88.83 | 163,089.0 |
MANKIND PHARMA LTD | 2,124.86 | 56.30 | 119,626.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 64.73 | 116,637.0 |
LUPIN LTD | 2,651.94 | 41.23 | 109,327.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 21.77 | 78,329.8 |
ABBOTT INDIA LTD | 1,284.66 | 49.53 | 63,622.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDOCO REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 21.20x |
Max industry PE | 105.97x |
Median industry PE | 41.23x |
Average industry PE | 49.17x |
You may also like the below Video Courses